[2021-07-16 17:10:55,676] {taskinstance.py:876} INFO - Dependencies all met for <TaskInstance: psotgrressdftest.news_postgres_table 2021-07-16T17:10:22.897945+00:00 [queued]>
[2021-07-16 17:10:55,840] {taskinstance.py:876} INFO - Dependencies all met for <TaskInstance: psotgrressdftest.news_postgres_table 2021-07-16T17:10:22.897945+00:00 [queued]>
[2021-07-16 17:10:55,841] {taskinstance.py:1067} INFO - 
--------------------------------------------------------------------------------
[2021-07-16 17:10:55,841] {taskinstance.py:1068} INFO - Starting attempt 1 of 1
[2021-07-16 17:10:55,842] {taskinstance.py:1069} INFO - 
--------------------------------------------------------------------------------
[2021-07-16 17:10:55,859] {taskinstance.py:1087} INFO - Executing <Task(PythonOperator): news_postgres_table> on 2021-07-16T17:10:22.897945+00:00
[2021-07-16 17:10:55,876] {standard_task_runner.py:52} INFO - Started process 11378 to run task
[2021-07-16 17:10:55,883] {standard_task_runner.py:76} INFO - Running: ['***', 'tasks', 'run', 'psotgrressdftest', 'news_postgres_table', '2021-07-16T17:10:22.897945+00:00', '--job-id', '1487', '--pool', 'default_pool', '--raw', '--subdir', 'DAGS_FOLDER/POSTGRESRSERS.py', '--cfg-path', '/tmp/tmpucnongnq', '--error-file', '/tmp/tmphxe83lbq']
[2021-07-16 17:10:55,885] {standard_task_runner.py:77} INFO - Job 1487: Subtask news_postgres_table
[2021-07-16 17:10:55,964] {logging_mixin.py:104} INFO - Running <TaskInstance: psotgrressdftest.news_postgres_table 2021-07-16T17:10:22.897945+00:00 [running]> on host 13346afafa5b
[2021-07-16 17:10:56,094] {taskinstance.py:1282} INFO - Exporting the following env vars:
AIRFLOW_CTX_DAG_OWNER=***
AIRFLOW_CTX_DAG_ID=psotgrressdftest
AIRFLOW_CTX_TASK_ID=news_postgres_table
AIRFLOW_CTX_EXECUTION_DATE=2021-07-16T17:10:22.897945+00:00
AIRFLOW_CTX_DAG_RUN_ID=manual__2021-07-16T17:10:20.784615+00:00
[2021-07-16 17:10:56,242] {logging_mixin.py:104} INFO - [('SHAREHOLDER ALERT: Robbins LLP Reminds Investors That AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading Shareholders', Decimal('0.0601')), ('ROSEN, A LEADING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8074')), ('ROSEN, A TOP RANKED FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8700')), ('ACRX INVESTOR ALERT: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.8192')), ('SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX', Decimal('-0.1697')), ('ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX', Decimal('0.8567')), ('AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the US', Decimal('0.7506')), ('ACRX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.3400')), ('SHAREHOLDER ALERT: Robbins LLP Reminds Investors of a Class Action Against AcelRX Pharmaceuticals, Inc. (ACRX)', Decimal('0.4466')), ('ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100k to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX', Decimal('0.6808')), ('AcelRx Announces Agreement with FDA Addressing the Warning Letter Received for DSUVIA® Promotional Materials', Decimal('0.2023')), ('ACRX DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors With LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.5950')), ('ACRX LOSS ALERT: ROSEN, A GLOBALLY RECOGNIZED INVESTOR LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.8020')), ('SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('Should Drug Manufacturers - Specialty & Generic Stock AcelRx Pharmaceuticals Inc (ACRX) Be in Your Portfolio Tuesday?', Decimal('0.0000')), ('Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AcelRx, Ocugen, Tarena, and DraftKings and Encourages Investors to Contact the Firm', Decimal('0.3182')), ('Rosen, A Top Ranked Law Firm, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8442')), ('Portnoy Law: Lawsuit Filed On Behalf of AcelRx Pharmaceuticals, Inc. Investors', Decimal('-0.2263')), ('AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) At Current Prices: Is It Worth Investing In?', Decimal('0.2263')), ('AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) surprises Wall Street with -1.47% stock price loss', Decimal('-0.1027')), ('INVESTOR ACTION NTOICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('SHAREHOLDER ALERT: Robbins LLP Announces that AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading Shareholders', Decimal('0.0601')), ('AcelRx, Aguettant Ink Licensing Agreements For Dzuveo And Two Prefilled Syringe Products', Decimal('0.2732')), ('AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Stock Forecast for 2021: Bullish Signs Point to $9 per Share', Decimal('0.2960')), ('Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.3400')), ('AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results', Decimal('0.0000')), ('Most Active Mid-Day Drug Manufacturer Stocks: Sundial Growers Inc. (NASDAQ:SNDL), Aurora Cannabis Inc. (NASDAQ:ACB), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Solid Biosciences Inc. (NASDAQ:SLDB).', Decimal('0.5563')), ('The Law Offices of Frank R. Cruz Announces Investigation of AcelRx Pharmaceuticals, Inc. (ACRX) on Behalf of Investors', Decimal('0.0000')), ('Cloopen Group Holding Limited (NYSE: RAAS), Athira Pharma Inc. (NASDAQ: ATHA), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) Face Securities Laws Violation Lawsuit', Decimal('-0.5859')), ('When Will AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Become Profitable?', Decimal('0.4404')), ('AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Following Use of DSUVIA® for Acute Pain in Hospital Settings', Decimal('-0.1027')), ('ACELRX PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AcelRx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm', Decimal('0.6037')), ('AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®', Decimal('0.0000')), ('AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results - PRNewswire', Decimal('0.0000')), ('Pomerantz Law Firm Announces the Filing of a Class Action Against AcelRx Pharmaceuticals, Inc. and Certain Officers - ACRX', Decimal('0.2732')), ('AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA®', Decimal('-0.5106')), ('Healthcare Stocks Making Moves Wednesday: ACRX, GBS, GRAMF, LOWLF, AHPI, ALNA, GKOS, WORX', Decimal('0.0000')), ('DEADLINE ALERT for SPCE, FREQ, ACRX, and RLX: The Law', Decimal('0.4466')), ('Why AcelRx Pharmaceuticals Stock Is Sinking Today', Decimal('0.0000')), ('ACRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('ACRX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline – ACRX', Decimal('0.8345')), ('AcelRx Announces Underwritten Public Offering of Common Stock', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors', Decimal('0.0000')), ('SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('0.4466')), ('AcelRx Pharmaceuticals: Waiting For The Numbers To Close The Gap', Decimal('0.0000')), ('Analysts Are Upgrading AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) After Its Latest Results', Decimal('0.0000')), ('AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements', Decimal('0.0000')), ('Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.2263')), ('AcelRx Pharmaceuticals: Moving Closer To An Attractive Risk-Reward', Decimal('0.4404')), ('Viral video: Monkey opens liquor bottle and starts drinking like a boss', Decimal('0.3612')), ('Bay Area medical technology companies had a mixed year. Natera had a good one. - Silicon Valley Business Journal', Decimal('0.4404')), ('SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100000 to Contact the Firm', Decimal('-0.1779')), ('The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors', Decimal('0.2960')), ('Where Does AcelRx Pharmaceuticals Inc (ACRX) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Has Gained 3.47% This Week?', Decimal('0.3818')), ('AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase', Decimal('0.0000')), ('Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now?', Decimal('0.4404')), ('AcelRx Announces DSUVIA® Added to the US Department of Defense"s Joint Deployment Formulary', Decimal('0.0000')), ('AcelRx Awarded US Army Contract for DSUVIA® - PRNewswire', Decimal('0.4019')), ('Will AcelRx Pharmaceuticals (ACRX) Report Negative Q4 Earnings? What You Should Know', Decimal('-0.5719')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry?', Decimal('0.2023')), ('AcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA®', Decimal('0.1280')), ('AcelRx Pharmaceuticals: A Bullish View In 3 Song Titles', Decimal('0.0000')), ('Securities Suit Claims AcelRx Pharmaceuticals Misrepresented Risks of Dsuvia Pain Medication | The Recorder', Decimal('-0.4939')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock a Good Value Monday?', Decimal('0.6486')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock a Great Value?', Decimal('0.7579')), ('AcelRx Pharmaceuticals: The $1 Million Questions', Decimal('0.0000')), ('AcelRx Pharma sinks as FDA issues warning letter on Dsuvia claims', Decimal('-0.3400')), ('Study of DSUVIA® Showing Significant Reduction in Postoperative Opioids and Better OBAS Scores Compared to Control Group to be Presented at the American Society of Regional Anesthesia (ASRA) Annual Meeting', Decimal('0.5719')), ('Opioid pain drug maker AcelRx made "false and misleading claims," FDA says. The marketing was discontinued in 2019, company says. - San Francisco Business Times', Decimal('-0.7184')), ('AcelRx Announces DSUVIA® Milestone C Approval and Provides Business Update', Decimal('0.4767')), ('Tetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration', Decimal('0.6486')), ('Tetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration', Decimal('0.6486')), ('AcelRx Pharmaceuticals Inc (ACRX) Q1 2020 Earnings Call Transcript', Decimal('0.0000')), ('AcelRx Pharmaceuticals Inc. Is Soaring -- Should You Be Buying?', Decimal('0.0000')), ('Do Options Traders Know Something About AcelRx (ACRX) Stock We Don"t?', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces DSUVIA™ as Brand Name for ARX-04 in the United States', Decimal('0.4215')), ('Why AcelRx Pharmaceuticals (NASDAQ: ACRX) still is betting on pain for a gain - San Francisco Business Times', Decimal('0.0258')), ('AcelRx Pharmaceuticals: Finally Light At The End Of The Tunnel', Decimal('0.0000')), ('INVESTOR ALERT: Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. Filed By Glancy Binkow & Goldberg LLP', Decimal('0.2577')), ('Bionano Genomics to join Russell 3000 Index, while AcelRx Pharmaceuticals to see deletion among healthcare stocks', Decimal('0.2960')), ('Here"s Why AcelRx Pharmaceuticals Fell as Much as 14% Today', Decimal('0.0000')), ('AcelRx Pharmaceuticals Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients with Postoperative Pain', Decimal('-0.5106')), ('AcelRx Gains on Dsuvia Study Results', Decimal('0.3400')), ('2 Penny Stocks That Could Make You Filthy Rich', Decimal('0.5574')), ('The Effort to Reduce Opioid Use Gets a Boost From New Drugs', Decimal('0.4019')), ('SHAREHOLDER ALERT: Robbins LLP Reminds Investors That AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading Shareholders', Decimal('0.0601')), ('ROSEN, A LEADING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8074')), ('Is AcelRx Pharmaceuticals Inc (ACRX) a Leader in the Drug Manufacturers - Specialty & Generic Industry?', Decimal('0.0000')), ('ROSEN, A TOP RANKED FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8700')), ('ACRX INVESTOR ALERT: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.8192')), ('ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX', Decimal('0.8567')), ('SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX', Decimal('-0.1697')), ('AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the US', Decimal('0.7506')), ('ACRX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.3400')), ('SHAREHOLDER ALERT: Robbins LLP Reminds Investors of a Class Action Against AcelRX Pharmaceuticals, Inc. (ACRX)', Decimal('0.4466')), ('ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100k to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX', Decimal('0.6808')), ('AcelRx Announces Agreement with FDA Addressing the Warning Letter Received for DSUVIA® Promotional Materials', Decimal('0.2023')), ('ACRX DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors With LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.5950')), ('ACRX LOSS ALERT: ROSEN, A GLOBALLY RECOGNIZED INVESTOR LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.8020')), ('SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('Should Drug Manufacturers - Specialty & Generic Stock AcelRx Pharmaceuticals Inc (ACRX) Be in Your Portfolio Tuesday?', Decimal('0.0000')), ('Rosen, A Top Ranked Law Firm, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8442')), ('Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AcelRx, Ocugen, Tarena, and DraftKings and Encourages Investors to Contact the Firm', Decimal('0.3182')), ('Portnoy Law: Lawsuit Filed On Behalf of AcelRx Pharmaceuticals, Inc. Investors', Decimal('-0.2263')), ('INVESTOR ACTION NTOICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) At Current Prices: Is It Worth Investing In?', Decimal('0.2263')), ('AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) surprises Wall Street with -1.47% stock price loss', Decimal('-0.1027')), ('INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('SHAREHOLDER ALERT: Robbins LLP Announces that AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading Shareholders', Decimal('0.0601')), ('AcelRx, Aguettant Ink Licensing Agreements For Dzuveo And Two Prefilled Syringe Products', Decimal('0.2732')), ('AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Stock Forecast for 2021: Bullish Signs Point to $9 per Share', Decimal('0.2960')), ('Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.3400')), ('AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results', Decimal('0.0000')), ('Most Active Mid-Day Drug Manufacturer Stocks: Sundial Growers Inc. (NASDAQ:SNDL), Aurora Cannabis Inc. (NASDAQ:ACB), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Solid Biosciences Inc. (NASDAQ:SLDB).', Decimal('0.5563')), ('The Law Offices of Frank R. Cruz Announces Investigation of AcelRx Pharmaceuticals, Inc. (ACRX) on Behalf of Investors', Decimal('0.0000')), ('Cloopen Group Holding Limited (NYSE: RAAS), Athira Pharma Inc. (NASDAQ: ATHA), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) Face Securities Laws Violation Lawsuit', Decimal('-0.5859')), ('When Will AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Become Profitable?', Decimal('0.4404')), ('ACELRX PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AcelRx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm', Decimal('0.6037')), ('AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Following Use of DSUVIA® for Acute Pain in Hospital Settings', Decimal('-0.1027')), ('AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®', Decimal('0.0000')), ('AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results - PRNewswire', Decimal('0.0000')), ('Pomerantz Law Firm Announces the Filing of a Class Action Against AcelRx Pharmaceuticals, Inc. and Certain Officers - ACRX', Decimal('0.2732')), ('AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA®', Decimal('-0.5106')), ('Healthcare Stocks Making Moves Wednesday: ACRX, GBS, GRAMF, LOWLF, AHPI, ALNA, GKOS, WORX', Decimal('0.0000')), ('DEADLINE ALERT for SPCE, FREQ, ACRX, and RLX: The Law', Decimal('0.4466')), ('Why AcelRx Pharmaceuticals Stock Is Sinking Today', Decimal('0.0000')), ('ACRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('ACRX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline – ACRX', Decimal('0.8345')), ('DEADLINE ALERT for FREQ, ACRX, RLX, HPMT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders', Decimal('0.4466')), ('AcelRx Announces Underwritten Public Offering of Common Stock', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors', Decimal('0.0000')), ('SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('0.4466')), ('AcelRx Pharmaceuticals: Waiting For The Numbers To Close The Gap', Decimal('0.0000')), ('Analysts Are Upgrading AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) After Its Latest Results', Decimal('0.0000')), ('AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements', Decimal('0.0000')), ('Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.2263')), ('AcelRx Pharmaceuticals: Moving Closer To An Attractive Risk-Reward', Decimal('0.4404')), ('Viral video: Monkey opens liquor bottle and starts drinking like a boss', Decimal('0.3612')), ('SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100000 to Contact the Firm', Decimal('-0.1779')), ('The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors', Decimal('0.2960')), ('Where Does AcelRx Pharmaceuticals Inc (ACRX) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Has Gained 3.47% This Week?', Decimal('0.3818')), ('AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase', Decimal('0.0000')), ('Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now?', Decimal('0.4404')), ('AcelRx Announces DSUVIA® Added to the US Department of Defense"s Joint Deployment Formulary', Decimal('0.0000')), ('AcelRx Awarded US Army Contract for DSUVIA® - PRNewswire', Decimal('0.4019')), ('Will AcelRx Pharmaceuticals (ACRX) Report Negative Q4 Earnings? What You Should Know', Decimal('-0.5719')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry?', Decimal('0.2023')), ('AcelRx Pharmaceuticals: A Bullish View In 3 Song Titles', Decimal('0.0000')), ('AcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA®', Decimal('0.1280')), ('Securities Suit Claims AcelRx Pharmaceuticals Misrepresented Risks of Dsuvia Pain Medication | The Recorder', Decimal('-0.4939')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock a Good Value Monday?', Decimal('0.6486')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock a Great Value?', Decimal('0.7579')), ('AcelRx Pharmaceuticals: The $1 Million Questions', Decimal('0.0000')), ('Study of DSUVIA® Showing Significant Reduction in Postoperative Opioids and Better OBAS Scores Compared to Control Group to be Presented at the American Society of Regional Anesthesia (ASRA) Annual Meeting', Decimal('0.5719')), ('Opioid pain drug maker AcelRx made "false and misleading claims," FDA says. The marketing was discontinued in 2019, company says. - San Francisco Business Times', Decimal('-0.7184')), ('AcelRx Announces DSUVIA® Milestone C Approval and Provides Business Update', Decimal('0.4767')), ('Tetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration', Decimal('0.6486')), ('Tetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration', Decimal('0.6486')), ('AcelRx Pharmaceuticals Inc (ACRX) Q1 2020 Earnings Call Transcript', Decimal('0.0000')), ('AcelRx Pharmaceuticals Inc. Is Soaring -- Should You Be Buying?', Decimal('0.0000')), ('Do Options Traders Know Something About AcelRx (ACRX) Stock We Don"t?', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces DSUVIA™ as Brand Name for ARX-04 in the United States', Decimal('0.4215')), ('Why AcelRx Pharmaceuticals (NASDAQ: ACRX) still is betting on pain for a gain - San Francisco Business Times', Decimal('0.0258')), ('AcelRx Pharmaceuticals: Finally Light At The End Of The Tunnel', Decimal('0.0000')), ('INVESTOR ALERT: Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. Filed By Glancy Binkow & Goldberg LLP', Decimal('0.2577')), ('Bionano Genomics to join Russell 3000 Index, while AcelRx Pharmaceuticals to see deletion among healthcare stocks', Decimal('0.2960')), ('Here"s Why AcelRx Pharmaceuticals Fell as Much as 14% Today', Decimal('0.0000')), ('AcelRx Pharmaceuticals Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients with Postoperative Pain', Decimal('-0.5106')), ('2 Penny Stocks That Could Make You Filthy Rich', Decimal('0.5574')), ('AcelRx Gains on Dsuvia Study Results', Decimal('0.3400')), ('SHAREHOLDER ALERT: Robbins LLP Reminds Investors That AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading Shareholders', Decimal('0.0601')), ('ROSEN, A LEADING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8074')), ('Is AcelRx Pharmaceuticals Inc (ACRX) a Leader in the Drug Manufacturers - Specialty & Generic Industry?', Decimal('0.0000')), ('ROSEN, A TOP RANKED FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8700')), ('ACRX INVESTOR ALERT: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.8192')), ('ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX', Decimal('0.8567')), ('SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ACRX', Decimal('-0.1697')), ('AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the US', Decimal('0.7506')), ('ACRX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.3400')), ('SHAREHOLDER ALERT: Robbins LLP Reminds Investors of a Class Action Against AcelRX Pharmaceuticals, Inc. (ACRX)', Decimal('0.4466')), ('ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses Over $100k to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX', Decimal('0.6808')), ('AcelRx Announces Agreement with FDA Addressing the Warning Letter Received for DSUVIA® Promotional Materials', Decimal('0.2023')), ('ACRX DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors With LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.5950')), ('ACRX LOSS ALERT: ROSEN, A GLOBALLY RECOGNIZED INVESTOR LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ACRX', Decimal('0.8020')), ('SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('Should Drug Manufacturers - Specialty & Generic Stock AcelRx Pharmaceuticals Inc (ACRX) Be in Your Portfolio Tuesday?', Decimal('0.0000')), ('Rosen, A Top Ranked Law Firm, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX', Decimal('0.8442')), ('Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AcelRx, Ocugen, Tarena, and DraftKings and Encourages Investors to Contact the Firm', Decimal('0.3182')), ('Portnoy Law: Lawsuit Filed On Behalf of AcelRx Pharmaceuticals, Inc. Investors', Decimal('-0.2263')), ('INVESTOR ACTION NTOICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) At Current Prices: Is It Worth Investing In?', Decimal('0.2263')), ('AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) surprises Wall Street with -1.47% stock price loss', Decimal('-0.1027')), ('INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm', Decimal('-0.1779')), ('SHAREHOLDER ALERT: Robbins LLP Announces that AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading Shareholders', Decimal('0.0601')), ('AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Stock Forecast for 2021: Bullish Signs Point to $9 per Share', Decimal('0.2960')), ('AcelRx, Aguettant Ink Licensing Agreements For Dzuveo And Two Prefilled Syringe Products', Decimal('0.2732')), ('Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.3400')), ('AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results', Decimal('0.0000')), ('Most Active Mid-Day Drug Manufacturer Stocks: Sundial Growers Inc. (NASDAQ:SNDL), Aurora Cannabis Inc. (NASDAQ:ACB), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Solid Biosciences Inc. (NASDAQ:SLDB).', Decimal('0.5563')), ('The Law Offices of Frank R. Cruz Announces Investigation of AcelRx Pharmaceuticals, Inc. (ACRX) on Behalf of Investors', Decimal('0.0000')), ('Cloopen Group Holding Limited (NYSE: RAAS), Athira Pharma Inc. (NASDAQ: ATHA), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) Face Securities Laws Violation Lawsuit', Decimal('-0.5859')), ('When Will AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Become Profitable?', Decimal('0.4404')), ('ACELRX PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AcelRx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm', Decimal('0.6037')), ('AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Following Use of DSUVIA® for Acute Pain in Hospital Settings', Decimal('-0.1027')), ('AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®', Decimal('0.0000')), ('AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results - PRNewswire', Decimal('0.0000')), ('Pomerantz Law Firm Announces the Filing of a Class Action Against AcelRx Pharmaceuticals, Inc. and Certain Officers - ACRX', Decimal('0.2732')), ('AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA®', Decimal('-0.5106')), ('Healthcare Stocks Making Moves Wednesday: ACRX, GBS, GRAMF, LOWLF, AHPI, ALNA, GKOS, WORX', Decimal('0.0000')), ('DEADLINE ALERT for SPCE, FREQ, ACRX, and RLX: The Law', Decimal('0.4466')), ('Why AcelRx Pharmaceuticals Stock Is Sinking Today', Decimal('0.0000')), ('ACRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('ACRX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AcelRx Pharmaceuticals, Inc. Investors of Class Action and Encourages Investors to Contact the Firm', Decimal('0.6249')), ('EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline – ACRX', Decimal('0.8345')), ('DEADLINE ALERT for FREQ, ACRX, RLX, HPMT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders', Decimal('0.4466')), ('AcelRx Announces Underwritten Public Offering of Common Stock', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors', Decimal('0.0000')), ('SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('0.4466')), ('AcelRx Pharmaceuticals: Waiting For The Numbers To Close The Gap', Decimal('0.0000')), ('Analysts Are Upgrading AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) After Its Latest Results', Decimal('0.0000')), ('AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements', Decimal('0.0000')), ('Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against AcelRx Pharmaceuticals, Inc. (ACRX)', Decimal('-0.2263')), ('AcelRx Pharmaceuticals: Moving Closer To An Attractive Risk-Reward', Decimal('0.4404')), ('Viral video: Monkey opens liquor bottle and starts drinking like a boss', Decimal('0.3612')), ('SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100000 to Contact the Firm', Decimal('-0.1779')), ('The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) Investors', Decimal('0.2960')), ('Where Does AcelRx Pharmaceuticals Inc (ACRX) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Has Gained 3.47% This Week?', Decimal('0.3818')), ('AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase', Decimal('0.0000')), ('Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now?', Decimal('0.4404')), ('AcelRx Announces DSUVIA® Added to the US Department of Defense"s Joint Deployment Formulary', Decimal('0.0000')), ('AcelRx Awarded US Army Contract for DSUVIA® - PRNewswire', Decimal('0.4019')), ('Will AcelRx Pharmaceuticals (ACRX) Report Negative Q4 Earnings? What You Should Know', Decimal('-0.5719')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock at the Top of the Drug Manufacturers - Specialty & Generic Industry?', Decimal('0.2023')), ('AcelRx Pharmaceuticals: A Bullish View In 3 Song Titles', Decimal('0.0000')), ('AcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA®', Decimal('0.1280')), ('Securities Suit Claims AcelRx Pharmaceuticals Misrepresented Risks of Dsuvia Pain Medication | The Recorder', Decimal('-0.4939')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock a Good Value Monday?', Decimal('0.6486')), ('Is AcelRx Pharmaceuticals Inc (ACRX) Stock a Great Value?', Decimal('0.7579')), ('AcelRx Pharmaceuticals: The $1 Million Questions', Decimal('0.0000')), ('Study of DSUVIA® Showing Significant Reduction in Postoperative Opioids and Better OBAS Scores Compared to Control Group to be Presented at the American Society of Regional Anesthesia (ASRA) Annual Meeting', Decimal('0.5719')), ('Opioid pain drug maker AcelRx made "false and misleading claims," FDA says. The marketing was discontinued in 2019, company says. - San Francisco Business Times', Decimal('-0.7184')), ('AcelRx Announces DSUVIA® Milestone C Approval and Provides Business Update', Decimal('0.4767')), ('Tetraphase Announces Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration', Decimal('0.6486')), ('Tetraphase Announces Second Amendment to Merger Agreement with AcelRx Pharmaceuticals for Increased Consideration', Decimal('0.6486')), ('AcelRx Pharmaceuticals Inc (ACRX) Q1 2020 Earnings Call Transcript', Decimal('0.0000')), ('AcelRx Pharmaceuticals Inc. Is Soaring -- Should You Be Buying?', Decimal('0.0000')), ('Do Options Traders Know Something About AcelRx (ACRX) Stock We Don"t?', Decimal('0.0000')), ('AcelRx Pharmaceuticals Announces DSUVIA™ as Brand Name for ARX-04 in the United States', Decimal('0.4215')), ('Why AcelRx Pharmaceuticals (NASDAQ: ACRX) still is betting on pain for a gain - San Francisco Business Times', Decimal('0.0258')), ('AcelRx Pharmaceuticals: Finally Light At The End Of The Tunnel', Decimal('0.0000')), ('INVESTOR ALERT: Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. Filed By Glancy Binkow & Goldberg LLP', Decimal('0.2577')), ('Bionano Genomics to join Russell 3000 Index, while AcelRx Pharmaceuticals to see deletion among healthcare stocks', Decimal('0.2960')), ('Here"s Why AcelRx Pharmaceuticals Fell as Much as 14% Today', Decimal('0.0000')), ('AcelRx Pharmaceuticals Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients with Postoperative Pain', Decimal('-0.5106')), ('2 Penny Stocks That Could Make You Filthy Rich', Decimal('0.5574')), ('AcelRx Gains on Dsuvia Study Results', Decimal('0.3400'))]
[2021-07-16 17:10:56,251] {python.py:151} INFO - Done. Returned value was: None
[2021-07-16 17:10:56,269] {taskinstance.py:1191} INFO - Marking task as SUCCESS. dag_id=psotgrressdftest, task_id=news_postgres_table, execution_date=20210716T171022, start_date=20210716T171055, end_date=20210716T171056
[2021-07-16 17:10:56,326] {taskinstance.py:1245} INFO - 1 downstream tasks scheduled from follow-on schedule check
[2021-07-16 17:10:56,374] {local_task_job.py:151} INFO - Task exited with return code 0
